100% Quality Guarantee
PhD-Level Technical Support
Key Features

XENP28278 Biosimilar (ENPP3) Antibody (HDBS0131)

SKU HDBS0131
Antibody Type Biosimilar Reference Antibody
Applications IHC
Applications FC
Applications Drug Development
Applications Pharmacokinetics
Disease Area Cancer
Protein ENPP3
Reactivity Human
Host Species Humanized
Isotype IgG1
€431

Request a formal quotation

A PDF quote with its own quote number, ready for your purchasing office to raise a PO against. Back within 4 working hours, from a PhD scientist — not an autoresponder.

  • PO-ready PDFQuote number, VAT, Incoterms
  • Volume pricing appliedDiscounts from 2 kits up
  • Valid 30 daysPrices held while you get sign-off
Anything we should know? optional

No account needed. We use your details only to prepare and send this quote. If it's urgent, say so in the box and we'll come back the same working day.

Global Shipping: 80+ Countries
White Glove Service: Available upon request
Batch Consistency: Contact Sales
Distributors: 60+ Countries

Description

system_update_altDatasheet

XENP28278 Biosimilar (ENPP3) Antibody (HDBS0131)

The Xenp28278 Biosimilar ENPP3 Antibody is a cutting-edge product designed for research involving ENPP3, a cell surface enzyme that plays a key role in various biological processes including cell growth, adhesion, and migration. This biosimilar antibody, produced through advanced biotechnological processes, offers exceptional specificity and sensitivity for detecting ENPP3 in human samples.With its high reactivity and validation for use in a variety of applications including Western blot and immunohistochemistry, this antibody enables accurate detection and analysis of ENPP3 protein expression in different cell types and tissues.

Its reliability and precision make it an excellent tool for studying the function and regulation of ENPP3 in the context of cancer, inflammation, and other disease processes.ENPP3, also known as ectonucleotide pyrophosphatase/phosphodiesterase 3, is involved in diverse physiological and pathological pathways, making it a promising target for therapeutic development in conditions such as cancer, bone metabolism disorders, and vascular calcification. Investigating the role of ENPP3 and its interactions with other molecules can provide valuable insights for developing novel treatments and improving patient outcomes.

View AllClose

0 Reviews

0
Based on 0 reviews

No reviews yet. Be the first to share your experience!

View AllClose